Molecular Diagnostics
Streamlined Approach Discovered for Treating Bowel Cancer
More than 4,000 Australians die from bowel cancer each year, and more than 17,000 new cases of this cancer will be diagnosed in 2018. Scientists are working to understand the genetic drivers of bowel cancer, with a special interest in those cancers which are the hardest to treat, and which have the poorest prognosis. More...02 May 2018
Metagenomic Sequencing Can Diagnose Cases of Meningitis
Subacute and chronic meningitis are diagnostically challenging given the wide range of potential infectious, autoimmune, neoplastic, paraneoplastic, parameningeal, and toxic causes. Securing a final diagnosis can require weeks or months of testing or remain unsolved, necessitating empirical treatment approaches that may be ineffective or even harmful. More...01 May 2018
Treponemal Subspecies Discriminated by LAMP
Human yaws is a tropical skin disease of children caused by the bacterium Treponema pallidum subsp. pertenue (TPE). Skin ulcers are the most characteristic clinical manifestations associated with infection in all three active disease stages, primary, secondary, and tertiary yaws. More...26 Apr 2018
Molecular Technology Identifies Potential Biomarker for Cancer
For patients with early-stage non-small cell lung cancer (NSCLC), the only recommended treatment option is surgery. After complete resection patients with disease at the same stage experience different outcomes, and within five years a third of patients relapse. More...26 Apr 2018
Assay Detects Hepatitis B in Multiple Specimens
Hepatitis B virus (HBV) infection has led to more than 686,000 deaths worldwide per year. Approximately two billion individuals worldwide are infected with HBV and are at risk of developing cirrhosis and hepatocellular carcinoma, which ranks fifth in terms of malignant cancer mortality. More...25 Apr 2018
Genetic Variant Identified As Better Marker for CV Disease
A newly identified subset of a known genetic variant found primarily in individuals of South Asian descent may be a better marker for carriers of heart dysfunction in this population and that individuals with this genetic variant are more likely to develop early signs of hypertrophic cardiomyopathy. More...24 Apr 2018
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Sample Transportation System
Tempus1800 Necto
In Other News
CSF Examined for Enteroviral Nervous System Infection
Blood Test Predicts Onset of TB in Advance
Genetic Link to IBS Identified in Women
Genetic Test May Improve Post-Stent Treatment Outcome
Amino Acids Can Predict CV Disease Risk in Women
Rapid Test Developed for Hepatitis C Infections
Nanopore Method Developed for Genetic Screening
Aggressive Meningioma Linked to Transcription Factor Activity
Gut Microbiome Analysis Predicts Hospitalizations in Cirrhosis
Genomic Test Detects Lynch Syndrome in Colorectal Cancer
Potential Genetic Link Identified in SIDS
Novel RNA Blood Test Launched for Fibromyalgia
Molecular Diagnostic Tool Developed for Chronic Endometritis
New Osteoarthritis Genes Discovered
Urinary Gene-Based Test Detects Bladder Cancer
Cervical Fluid Test Developed for Gynecological Cancers
Rapid Detection of Legionella Offered for Commercial Water Systems
New Fingerprint Assay Accurately Identifies Users of Heroin and Cocaine
Chromosome Interaction Profiling Reveals Cancer Risk Genes
Circulating Blood Markers Identified for Abnormal Heart Rhythms
Synesthesia Family Exomes Lead to Rare Gene Variants
Distinct Epigenetic Features Found in Alzheimer's Brains
Typhoid Fever Bacteria Sequencing Reveals Drug Resistance Genes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
